IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Financial Information
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
- 2020
- 2021
- 2022
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Current Assets | 12,975 | 20,808 | 19,241 |
| Non-Current Assets | 36,425 | 37,448 | 27,706 |
| Total Assets | 49,400 | 58,256 | 46,946 |
| Current Liabilities | 1,044 | 1,846 | 18,283 |
| Non-Current Liabilities | 1,060 | 17,649 | 2,354 |
| Total Liabilities | 2,104 | 19,496 | 20,637 |
| Capital | 4,849 | 4,866 | 4,866 |
| Retained Earnings | -6,507 | -19,519 | -32,252 |
| Total Equity | 47,296 | 38,761 | 26,309 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Sales | 0 | 909 | 0 |
| Operating Profit | -5,287 | -13,011 | -3,995 |
| Profit before Income Tax | -4,126 | -13,071 | -3,935 |
| Net Profit | -4,126 | -13,071 | -3,935 |
